Monthly Stock Analysis: Align Technology, Inc. (ALGN)
Publication Date: September 22, 2024
Company Overview
Align Technology, Inc. (ALGN), based in Tempe, Arizona, is a leading player in the healthcare sector, primarily focusing on innovative dental solutions. Best known for its flagship product, the Invisalign clear aligners, Align also manufactures iTero intraoral scanners, catering to both orthodontists and general dental practitioners worldwide. Established in 1997, Align Technology is committed to enhancing dental practices by providing a suite of advanced imaging systems and CAD/CAM services tailored to meet various orthodontic needs, with a strong focus on younger patients. As a prominent entity in the medical instruments and supplies industry, Align exemplifies the intersection of healthcare and cutting-edge technology.
Market Position and Investment Potential
The medical instruments and supplies industry is currently experiencing robust growth, driven by increasing demand for innovative medical technologies. Align Technology has reported total revenues of approximately $3.94 billion, highlighting its strong market presence and financial health. Analysts are optimistic about ALGN’s stock performance, setting a target high price of $350.00 amidst a recommendation to “buy.” The mean target price stands at $285.93, indicating potential for considerable growth from its current trading price of $252.85.
With 74,697,104 outstanding shares and a low short interest of approximately 4.69%, the stock signals that the majority of investors are holding long positions, reflecting confidence in the company’s future. The stock’s volatility is illustrated by its price range over the past year, fluctuating between a fifty-two week high of $335.40 and a low of $176.34.
Financial Performance and Outlook
ALGN’s financial performance underscores its stability and growth potential. Despite the absence of EBITDA data, the reported revenue and stock price metrics present an optimistic prospect for investors. The current stock price, which exceeds the fifty-day average of $232.61, suggests a positive trend in stock performance, reinforcing the view of a resilient company amidst market fluctuations.
Overall, with a favorable consensus from 12 analysts, an average recommendation score of 2.3, and a target price range reflecting significant potential for upward price movement, Align Technology, Inc. offers an appealing investment opportunity for those looking to capitalize on advancements in the healthcare market.
| Metric | Value |
|---|---|
| Market Cap | $18.9b |
| Total Debt | $129.1m |
| Total Cash | $782.1m |
| Shares Outstanding | 74.7m |
| Float Shares | 69.6m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.